Primary Site >> Colorectal Cancer

Gene >> SPAG17

  • 2009
  • 2013
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Synthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine.
PMID: 19119867
Ref: Potential of silver against human colon cancer: (synthesis, characterization and crystal structures of xylyl (Ortho, meta, &Para) linked bis-benzimidazolium salts and Ag(I)-NHC complexes: In vitro anticancer studies).
PMID: 23391345
Ref: Cyclopentadienyl-ruthenium(II) and iron(II) organometallic compounds with carbohydrate derivative ligands as good colorectal anticancer agents.
PMID: 25923600
Ref: New [(eta(5)-C5H5)Ru(N-N)(PPh3)][PF6] compounds: colon anticancer activity and GLUT-mediated cellular uptake of carbohydrate-appended complexes.
PMID: 27216868
Ref: Insights into the cytotoxic activity of the phosphane copper(I) complex [Cu(thp)4][PF6].
PMID: 27449160
Ref: Designing new iridium(iii) arene complexes of naphthoquinone derivatives as anticancer agents: a structure-activity relationship study.
PMID: 28138683
Ref: Therapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors.
PMID: 29066771
Ref: Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells.
PMID: 29262647
Ref: A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells.
PMID: 29321581
Ref: A potential method to improve the in vitro cytotoxicity of half-sandwich Os(ii) complexes against A2780 cells.
PMID: 29632937
Ref: Syntheses and biological studies of nitroimidazole conjugated heteroscorpionate ligands and related Cu(I) and Cu(II) complexes.
PMID: 30053534